We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics


Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Artificial Intelligence Helps Diagnose Leukemia

By LabMedica International staff writers
Posted on 29 Sep 2021
Print article
Image: The Navios EX flow cytometer offers a solution for advanced cytometry applications with workflows for high throughput laboratories (Photo courtesy of Beckman Coulter)
Image: The Navios EX flow cytometer offers a solution for advanced cytometry applications with workflows for high throughput laboratories (Photo courtesy of Beckman Coulter)
Multi-parameter flow cytometry (MFC) is a cornerstone in clinical decision making for leukemia and lymphoma. MFC data analysis requires manual gating of cell populations, which is time-consuming, subjective, and often limited to a two-dimensional space.

Typical symptoms of malignant B-cell lymphomas and related leukemias are that the lymph nodes become swollen, there is weight loss and fatigue, as well as fevers and infections. If such a cancer of the lymphatic system is suspected, the physician takes a blood or bone marrow sample and sends it to specialized laboratories for flow cytometry analysis.

Clinical Scientists and Bioinformaticians associated with University of Bonn (Bonn, Germany) and colleagues from other institutions present a workflow that allows existing artificial intelligence (AI) to adapt to multiple MFC protocols. They combined transfer learning (TL) with MFC data merging to increase the robustness of AI. The base dataset consists of around 18,000 training samples acquired using a 9-color MFC panel at Munich Leukemia Laboratory (MLL, Munich, Germany), between 2017 and 2018. Four additional MFC target datasets were obtained with different MFC panel compositions. All samples were analyzed on Navios flow cytometers (Beckman Coulter, Miami, FL, USA).

Flow cytometry is a method in which the blood cells flow past measurement sensors at high speed. The properties of the cells can be detected depending on their shape, structure or coloring. Detection and accurate characterization of pathological cells is important when making a diagnosis. The laboratories use "antibodies" that dock to the surface of the cells and are coupled to fluorescent dyes. Such markers can also be used to detect small differences between cancer cells and healthy blood cells. Flow cytometry generates large amounts of data. On average, more than 50,000 cells are measured per sample. These data are then typically analyzed on screen by plotting the expression of the markers used against each other.

The great new feature of the AI presented in the study lies in the possibility of knowledge transfer. Particularly smaller laboratories that cannot afford their own bioinformatics expertise and may also have too few samples to develop their own AI from scratch can benefit from this study. After a short training phase, during which the AI learns the specifics of the new laboratory, it can then draw on knowledge derived from many thousands of data sets.

Peter M. Krawitz, MD, PhD, a Professor at the Institute for Genomic Statistics and Bioinformatics and a senior author of the study, said, “The gold standard is diagnosis by hematologists, which can also take into account results of additional tests. The point of using AI is not to replace physicians, but to make the best use of the information contained in the data.”

The authors concluded their workflow extended deep learning models to multiple MFC panels and achieve high accuracy for multi-label classification across datasets. They addressed some of the previous challenges for automated flow cytometry classification by allowing models to be trained with smaller training sizes and generalizing models to work with multiple MFC panels. The workflow is a step toward making deep learning models robust so that AI for diagnostic MFC can move from the “proof of concept” stage into routine diagnostics. The study was published on September 17, 2021 in the journal Patterns.

Related Links:
University of Bonn
Munich Leukemia Laboratory
Beckman Coulter

Gold Supplier
Benchtop Auto Sample Transfer Processor
Cytology Sample Processor
SDSCP9000 CytoPath Processor
Gold Supplier
TBI Blood Test
i-STAT TBI Plasma Test
Vented Safety Enclosures
VSE Balance Enclosures

Print article


Molecular Diagnostics

view channel
Image: Absence of nuclear immunohistochemical staining of MSH2 protein (A) and presence of MLH1 protein (B) in urothelial cell carcinoma of the urinary bladder of a patient carrying a germline MSH2 mutation. Observe the nuclear staining in stromal cells as an internal control (Photo courtesy of Radboud University Nijmegen Medical Centre)

Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients

Lynch Syndrome (LS) is an inherited genetic disorder that carries a high risk of cancer. LS is caused by mutations affecting MLH1, MSH2, MSH6 or PMS2 genes. More than one in 300 people have LS but most... Read more


view channel
Image: The IMMULITE 2000 XPi Immunoassay System provides multiple tests on a single, easy-to-use analyzer, including the thyroid-stimulating immunoglobulin assay (Photo courtesy of Siemens Healthcare)

Immunoassays Evaluated for Thyroid-Stimulating Receptor Antibody in Graves’ Disease

Graves' disease (GD), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results... Read more


view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more


view channel

AI Accurately Detects and Diagnoses Colorectal Cancer from Tissue Scans As Well or Better Than Pathologists

Artificial intelligence (A) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study. The study, which was conducted by researchers... Read more


view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more


view channel

Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.